首页> 美国卫生研究院文献>Aging (Albany NY) >DOK3 is involved in microglial cell activation in neuropathic pain by interacting with GPR84
【2h】

DOK3 is involved in microglial cell activation in neuropathic pain by interacting with GPR84

机译:DoK3通过与GPR84进行交互参与神经病疼痛中的显微胶质细胞活化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Adaptor molecule downstream of kinase-3 (DOK3) is a vital regulator of innate immune responses in macrophages and B cells, and G-protein-coupled receptor 84 (GPR84) is significant in mediating the biosynthesis and maintenance of inflammatory mediators that are induced by neuropathic pain in microglia. In the present study, we determined the role of DOK3 in activating microglia-induced neuropathic pain and investigated the underlying mechanisms associated with GPR84. We found that knockdown of DOK3 in microglial cells dramatically reduced the levels of inflammatory factors, and we uncovered a physical association between DOK3 and GPR84 in the induction of inflammatory responses. We also observed that neuropathic pain and inflammatory responses induced by chronic constriction injury (CCI) of the sciatic nerve or intrathecal injection of a GPR84 agonist were compromised in DOK3-/- mice in vivo. Finally, enforced expression of DOK3 provoked inflammatory responses, and administration of pregabalin relieved neuropathic pain via inhibition of DOK3 expression. In conclusion, DOK3 induced neuropathic pain in mice by interacting with GPR84 in microglia. We hypothesize that targeting the adaptor protein DOK3 may open new avenues for pharmaceutical approaches to the alleviation of neuropathic pain in the spinal cord.
机译:在激酶-3(DOK3)下游的衔接子分子是巨噬细胞和B细胞中先天免疫应答的重要调节剂,并且G蛋白偶联受体84(GPR84)在介导诱导的生物合成和维持诱导的炎症介质方面是显着的微胶质细胞的神经性疼痛。在本研究中,我们确定了Dok3在激活微胶质细胞诱导的神经病疼痛中的作用,并研究了与GPR84相关的潜在机制。我们发现DoK3在微胶质细胞中的敲低显着降低了炎症因子的水平,并且我们在诱导炎症反应的诱导中发现了DoK3和GPR84之间的物理关联。我们还观察到,在体内的DOK3 - / - 小鼠中,坐骨神经或鞘内注射的慢性收缩损伤(CCI)诱导的慢性收缩损伤(CCI)诱导的神经性疼痛和炎症反应受到体内的DOK3 - / - 小鼠。最后,强制表达DOK3被引起的炎症反应,并通过抑制DOK3表达施用普瑞巴林的给药。总之,Dok3通过与微胶质菌中的GPR84相互作用诱发小鼠的神经病疼痛。我们假设靶向适配器蛋白DOK3可以打开用于缓解脊髓中神经性疼痛的药物方法的新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号